Successful treatment of a South African cat with effusive feline infectious peritonitis with remdesivir
Keywords:
feline infectious peritonitis, remdesivir, effusive, cats, coronavirus, GS-441524, ascites, treatment, felineAbstract
Historically, feline infectious peritonitis (FIP) has been considered almost invariably fatal. The recent COVID-19 pandemic has fuelled research in coronavirus pathophysiology and treatment. An unintended consequence is that we now have an effective treatment accessible for FIP. This paper reports on the successful resolution of immunohistochemistry-confirmed effusive FIP in an adolescent cat in South Africa following monotherapy with remdesivir at 4.9–5.6 mg/kg daily for 80 days.